Skip to main content
Premium Trial:

Request an Annual Quote

IP Genesis Debuts Novel DNA Sequencing Technology

NEW YORK, Jan. 28 - Start up bioinformatics company IP Genesis is introducing a new DNA sequencing and analysis technique developed at Argonne National Laboratory.


The technique was developed by former Argonne researcher Aleksandar Milosavljevic, who later founded IP Genesis.  Milosavljevic, a computer scientist and bioinformaticist, worked on the Human Genome Project at Argonne from 1992 to 1995.


The company has secured an exclusive license from Argonne to use the technique, Argonne said on Monday.


The technology, called Comparative Sequence Assembly, accelerates fragment assembly by comparing the unknown sequence to those from known and finished genomes.


"Fragments are put together by simultaneously maximizing mutual overlaps, plus their similarity to another reference nucleic acid sequence," explained Milosavljevic. "The more similarity there is, the larger the benefit in terms of the number of fragments you need."


Milosavljevic said that his method would accelerate cross-mammalian sequence assembly between 20 percent and 50 percent.


IP Genesis was formed one year ago and is based in Houston, Tex.


Milosavljevic said that he would be exploring licensing opportunities with a range of companies in the months to come.  IP Genesis may offer exclusive or nonexclusive licenses to the sequencing method, as well as consultant services to help companies implement this system.


Potential partners include bioinformatics companies, database providers, sequence assembly software providers, discovery companies and others, said Milosavljevic.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.